logo

iStock Rating

D
Details...
Enter Symbol click to research

ViroPharma Incorporated (NASDAQ: VPHM)

Sector: Medical

Current Price : $26.10

52 Week Low
$19.2452 Week High
$30.71
 

VIROPHARMA(NSDQ:VPHM)
VIROPHARMA is a leader in RNA virology and RNA antiviral drug discovery and development. The company is committed to the commercialization, development and discovery of antiviral pharmaceuticals. The company focuses on drug development and discovery activities for viral diseases including viral meningitis, viral respiratory infection, pneumonia, hepatitis C and influenza. Each year, a majority of the world''s population is afflicted by at least one of these diseases, and antiviral therapies are either inadequate or do not exist.
# Employees: 410
Address: 730 STOCKTON DRIVE,EXTON,PA,USA
Phone: 6104587300
Fax: 610-458-7380
Website: http://www.viropharma.com
Email:
Sector: Medical
Industry: MED-DRUGS
Executive Officers
Vincent J. Milano (Chairman;President & .CE.O.)
Charles A. Rowland (Jr.)
Chief Financial Officer (John J. Kirby)
Chief Accounting Officer;Vice President (Paul A. Brooke)
Director (William Claypool, M.D. ,Director,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 12/31/2012
Next Earnings Date(Expected): 5/7/2013
Mean EPS (Next Qtr): $0.05
Mean EPS (Year): $0.29
Mean Estimate(Long Term): $11.75
P/E Ratio(Based on EPS estimate): 89.690
Number of Estimates: 11
Shares Performance
Period vphm Compare to S&P
YTD 14.28 % 4.80 %
4 Weeks 9.79 % 9.91 %
12 Weeks -4.66 % -7.86 %
Shares Information
Analyst Coverage: Y
Avg Volume: 443261
Shares Outstanding: 65M
Market Cap: $1.70B
52 Week High: $30.71
52 Week Low: $19.24
P/E Ratio: 60.490
PEG Ratio: 7.630
Split: On 1/1/1990 vphm split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: -100.00 %
EPS Growth in Last Year: -100.00 %
Sales Growth in Last Quarter: 17.02 %
Sales Growth in Last Quarter: -26.85 %
Financials
Qtr Book Value: $2.26
Cash Flow/Share: $29.48
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Home | Login |Research | Earnings | Scans | Charts | Submit Article | Join Blog Network | Advertise | Subscribe to RSS

Terms of Use | Privacy Policy | Copyright 2012 all rights reserved
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.